1 “..., the manufacturer asked that the requested listing criteria be modified to reflect the two indications under review...”

2 “..., the manufacturer asked that the requested listing criteria be modified to reflect the two indications under review...”

3 “... that participate in the CDR review process asking that the use of omalizumab in asthma be re-reviewed in light...”

4 “... that participate in the CDR review process asking that the use of omalizumab in asthma be re-reviewed in light...”

5 “... effectiveness of levodopa/carbidopa in the treatment of Parkinson disease (PD). CDR was asked to review levodopa...”

6 “... effectiveness of levodopa/carbidopa in the treatment of Parkinson disease (PD). CDR was asked to review levodopa...”

7 “... of the draft CDR clinical and pharmacoeconomic reports, the manufacturer asked that the requested listing...”

8